# Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

> **NCT03804268** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 323 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **OTHER:** Vehicle
- **DRUG:** Pilocarpine HCl Ophthalmic Solution

## Key facts

- **NCT ID:** NCT03804268
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-21
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03804268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03804268, "Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03804268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*